Patients worldwide rely on Taj Pharma’s Anti-Cancer products to meet their medical needs. Ensuring an unrestricted supply of safe medicines is of critical importance to us, and doing so requires a secure, accountable supply chain of trusted partner companies. In 2018, Taj Pharma Oncology division completed audits of 9,892 suppliers globally, and more than 11,000 supplier audits were planned for 2019.
WordPress Tables Plugin